Introduction to Understanding And Overcoming Parp Inhibitor Resistance
Welcome to our comprehensive guide on Understanding And Overcoming Parp Inhibitor Resistance. Jos Jonkers, PhD, of The Netherlands Cancer Institute and Leiden University presents
Understanding And Overcoming Parp Inhibitor Resistance Comprehensive Overview
Timothy Yap, MBBS, PhD, FRCP, The University of Texas MD Anderson Cancer Center, Houston, TX, talks on Ioannis Gounaris, MD, PhD, of Merck, discusses tuvusertib-based combinations Anniina Färkkilä, MD, PhD, Helsinki University, Helsinki, Finland, describes strategies to reduce the incidence of
Overcoming resistance
Summary & Highlights for Understanding And Overcoming Parp Inhibitor Resistance
- Expert oncologists explore the mechanisms of
- Shannon N. Westin, MD, MPH, clinical investigator, Department of Gynecologic Oncology and Reproductive Medicine, The ...
- Alan D'Andrea, MD.
- Chair & Presenter, Susana Banerjee, MBBS, MA, FRCP, PhD, William J. Gradishar, MD, FASCO, FACP, and Maha Hussain, MD, ...
- Dr Adrienne Waks speaks to ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about the ...
In summary, understanding Understanding And Overcoming Parp Inhibitor Resistance gives us a better perspective.